Longitudinal assessment of antipneumococcal susceptibility in the United States.
about
National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance studyHigh genetic diversity of ciprofloxacin-nonsusceptible isolates of Streptococcus pneumoniae in Poland.In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone.Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance.Global fluoroquinolone resistance epidemiology and implictions for clinical use.Treating acute exacerbations of chronic bronchitis and community-acquired pneumonia: how effective are respiratory fluoroquinolones?Use of the respiratory fluoroquinolones for the outpatient management of community-acquired pneumoniaMutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy.Predicting the clinical efficacy of generic formulations of ceftriaxone.Reinterpretation of susceptibility data using current NCCLS breakpoint criteria.Antibiotic resistance in sputum isolates of Streptococcus pneumoniae in chronic obstructive pulmonary disease is related to antibiotic exposure.
P2860
Q24682283-BC120D93-49FC-4789-A455-7931AE2421B5Q33770218-28AE472A-6ED3-4446-B762-A09AA307540AQ34230118-404CB56B-BE66-494A-8B56-B56E16A56225Q34502866-1AFEDE74-23AC-4F98-B597-59B1D6D9BD87Q36337074-0A17BCB2-C85A-494D-96C9-BE3150F5BE6BQ36728602-C71F52DE-D6F4-441C-B7CE-735C25A9461CQ37719126-DAD61FCA-1104-4F89-A085-3555292657A4Q37733449-0D61DC09-CEEC-4B33-B430-470DCB0AC045Q40369183-7FF66525-9489-4CC6-BC45-D0F0E12AFB4FQ42858208-07811A2B-622F-42F0-959E-D3AE64BE919CQ44959691-2C2AC83A-E73F-44A7-86D4-9A4235834AFC
P2860
Longitudinal assessment of antipneumococcal susceptibility in the United States.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Longitudinal assessment of antipneumococcal susceptibility in the United States.
@ast
Longitudinal assessment of antipneumococcal susceptibility in the United States.
@en
Longitudinal assessment of antipneumococcal susceptibility in the United States.
@nl
type
label
Longitudinal assessment of antipneumococcal susceptibility in the United States.
@ast
Longitudinal assessment of antipneumococcal susceptibility in the United States.
@en
Longitudinal assessment of antipneumococcal susceptibility in the United States.
@nl
prefLabel
Longitudinal assessment of antipneumococcal susceptibility in the United States.
@ast
Longitudinal assessment of antipneumococcal susceptibility in the United States.
@en
Longitudinal assessment of antipneumococcal susceptibility in the United States.
@nl
P2093
P2860
P1476
Longitudinal assessment of antipneumococcal susceptibility in the United States.
@en
P2093
Clyde Thornsberry
Daniel F Sahm
Elena Karginova
Ian A Critchley
James A Karlowsky
Mark E Jones
Renée Blosser-Middleton
P2860
P304
P356
10.1128/AAC.46.8.2651-2655.2002
P407
P577
2002-08-01T00:00:00Z